Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132283127> ?p ?o ?g. }
- W3132283127 abstract "Abstract Background Antibody responses as serological markers of Plasmodium vivax infection have been shown to correlate with exposure, but little is known about the other factors that affect antibody responses in naturally infected people from endemic settings. To address this question, we studied IgG responses to novel serological exposure markers (SEMs) of P. vivax in three settings with different transmission intensity. Methodology We validated a panel of 34 SEMs in a Peruvian cohort with up to three years’ longitudinal follow-up using a multiplex platform and compared results to data from cohorts in Thailand and Brazil. Linear regression models were used to characterize the association between antibody responses and age, the number of detected blood-stage infections during follow-up, and time since previous infection. Receiver Operating Characteristic (ROC) analysis was used to test the performance of SEMs to identify P. vivax infections in the previous 9 months. Principal findings Antibody titers were associated with age, the number of blood-stage infections, and time since previous P. vivax infection in all three study sites. The association between antibody titers and time since previous P. vivax infection was stronger in the low transmission settings of Thailand and Brazil compared to the higher transmission setting in Peru. Of the SEMs tested, antibody responses to RBP2b had the highest performance for classifying recent exposure in all sites, with area under the ROC curve (AUC) = 0.83 in Thailand, AUC = 0.79 in Brazil, and AUC = 0.68 in Peru. Conclusions In low transmission settings, P. vivax SEMs can accurately identify individuals with recent blood-stage infections. In higher transmission settings, the accuracy of this approach diminishes substantially. We recommend using P. vivax SEMs in low transmission settings pursuing malaria elimination, but they are likely to be less effective in high transmission settings focused on malaria control. Author Summary Plasmodium vivax still poses a threat in many countries due to its ability to cause recurrent infections. Key to achieving the goal of malaria elimination is the ability to quickly detect and treat carriers of relapsing parasites. Failing to identify this transmission reservoir will hinder progress towards malaria elimination. Recently, novel serological markers of recent exposure to P. vivax (SEM) have been developed and validated in low transmission settings. It is still poorly understood what factors affect the antibody response to these markers when evaluated in contrasting endemic contexts. To determine the factors that influence the antibody response to SEM, we compared the antibody levels in three sites with different transmission intensity: Thailand (low), Brazil (moderate) and Peru (high). In this study, we found that transmission intensity plays a key role in the acquisition of the antibody repertoire to P . vivax . In highly endemic sites, it is likely that immunological memory resulting from a constant and sustained exposure will impact the performance of SEMs to detect individuals with recent exposure to P . vivax . In summary, SEMs that perform well in low transmission sites do not perform as well in high transmission regions." @default.
- W3132283127 created "2021-03-01" @default.
- W3132283127 creator A5001446475 @default.
- W3132283127 creator A5024161412 @default.
- W3132283127 creator A5036611116 @default.
- W3132283127 creator A5037867236 @default.
- W3132283127 creator A5037972059 @default.
- W3132283127 creator A5038487191 @default.
- W3132283127 creator A5043426673 @default.
- W3132283127 creator A5055338250 @default.
- W3132283127 creator A5056258333 @default.
- W3132283127 creator A5068252113 @default.
- W3132283127 creator A5086706223 @default.
- W3132283127 creator A5089304086 @default.
- W3132283127 date "2020-07-02" @default.
- W3132283127 modified "2023-10-06" @default.
- W3132283127 title "Heterogeneity in response to serological exposure markers of recentPlasmodium vivaxinfections in contrasting epidemiological contexts" @default.
- W3132283127 cites W103823305 @default.
- W3132283127 cites W1550073790 @default.
- W3132283127 cites W1592700378 @default.
- W3132283127 cites W1839670086 @default.
- W3132283127 cites W1872721700 @default.
- W3132283127 cites W1924088672 @default.
- W3132283127 cites W1970909319 @default.
- W3132283127 cites W1985453822 @default.
- W3132283127 cites W2004503813 @default.
- W3132283127 cites W2010506910 @default.
- W3132283127 cites W2068830954 @default.
- W3132283127 cites W2099551104 @default.
- W3132283127 cites W2111665585 @default.
- W3132283127 cites W2118415151 @default.
- W3132283127 cites W2119130553 @default.
- W3132283127 cites W2121437137 @default.
- W3132283127 cites W2124312641 @default.
- W3132283127 cites W2132078046 @default.
- W3132283127 cites W2132409323 @default.
- W3132283127 cites W2155612959 @default.
- W3132283127 cites W2162533730 @default.
- W3132283127 cites W2166895584 @default.
- W3132283127 cites W2169012335 @default.
- W3132283127 cites W2248884943 @default.
- W3132283127 cites W2264013405 @default.
- W3132283127 cites W2342607526 @default.
- W3132283127 cites W2524562796 @default.
- W3132283127 cites W2608589714 @default.
- W3132283127 cites W2743341280 @default.
- W3132283127 cites W2754579679 @default.
- W3132283127 cites W2760669860 @default.
- W3132283127 cites W2767025141 @default.
- W3132283127 cites W2911733880 @default.
- W3132283127 cites W2912330008 @default.
- W3132283127 cites W2969627647 @default.
- W3132283127 cites W2989618758 @default.
- W3132283127 cites W2991441442 @default.
- W3132283127 cites W3013394899 @default.
- W3132283127 cites W3023315501 @default.
- W3132283127 cites W3080829572 @default.
- W3132283127 cites W3126574749 @default.
- W3132283127 cites W4285662914 @default.
- W3132283127 cites W87464560 @default.
- W3132283127 doi "https://doi.org/10.1101/2020.07.01.20143503" @default.
- W3132283127 hasPublicationYear "2020" @default.
- W3132283127 type Work @default.
- W3132283127 sameAs 3132283127 @default.
- W3132283127 citedByCount "0" @default.
- W3132283127 crossrefType "posted-content" @default.
- W3132283127 hasAuthorship W3132283127A5001446475 @default.
- W3132283127 hasAuthorship W3132283127A5024161412 @default.
- W3132283127 hasAuthorship W3132283127A5036611116 @default.
- W3132283127 hasAuthorship W3132283127A5037867236 @default.
- W3132283127 hasAuthorship W3132283127A5037972059 @default.
- W3132283127 hasAuthorship W3132283127A5038487191 @default.
- W3132283127 hasAuthorship W3132283127A5043426673 @default.
- W3132283127 hasAuthorship W3132283127A5055338250 @default.
- W3132283127 hasAuthorship W3132283127A5056258333 @default.
- W3132283127 hasAuthorship W3132283127A5068252113 @default.
- W3132283127 hasAuthorship W3132283127A5086706223 @default.
- W3132283127 hasAuthorship W3132283127A5089304086 @default.
- W3132283127 hasBestOaLocation W31322831271 @default.
- W3132283127 hasConcept C107130276 @default.
- W3132283127 hasConcept C119599485 @default.
- W3132283127 hasConcept C126322002 @default.
- W3132283127 hasConcept C127413603 @default.
- W3132283127 hasConcept C159654299 @default.
- W3132283127 hasConcept C203014093 @default.
- W3132283127 hasConcept C22889606 @default.
- W3132283127 hasConcept C2778048844 @default.
- W3132283127 hasConcept C2778371730 @default.
- W3132283127 hasConcept C2779997623 @default.
- W3132283127 hasConcept C2781188995 @default.
- W3132283127 hasConcept C32611913 @default.
- W3132283127 hasConcept C45189115 @default.
- W3132283127 hasConcept C58471807 @default.
- W3132283127 hasConcept C60644358 @default.
- W3132283127 hasConcept C71924100 @default.
- W3132283127 hasConcept C72563966 @default.
- W3132283127 hasConcept C761482 @default.
- W3132283127 hasConcept C76318530 @default.
- W3132283127 hasConcept C86803240 @default.
- W3132283127 hasConceptScore W3132283127C107130276 @default.